Company: SSEA
Filing Date: 2025-03-05
Form Type: DRS
Source: 0001829126-25-001469
Chunk: 15

Company: STARRY SEA ACQUISITION CORP
Filing Date: 2025-03-05
Form: DRS
Chunk 15
---
 business combination with a target company that is based outside of the PRC and which may therefore make it more likely that we will need to target a business combination with a target company located in the PRC.] For further risk factors relating to this offering and our company, please see “Risks Factors” beginning on page [●].

We are an “emerging growth company” under applicable federal securities laws and will be subject to reduced public company reporting requirements. Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page [●] for a discussion of information that should be considered in connection with an investment in our securities. Investors will not be entitled to protections normally afforded to investors in Rule 419 blank check offerings.

Neither the U.S. Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

No offer or invitation to subscribe for units may be made to the public in the Cayman Islands.

|          |     | Price to Public |            |     | Underwriting Discounts and Commissions(1)(2) |           |     | Proceeds, before 
 Expenses, to us  |            |
|:---------|:----|:----------------|-----------:|:----|:---------------------------------------------|----------:|:----|:-----------------|-----------:|
| Per Unit |     | $               |      10.00 |     | $                                            |      0.20 |     | $                |       9.80 |
| Total    |     | $               | 50,000,000 |     | $                                            | 1,000,000 |     | $                | 49,000,000 |

| (1) | $0.20 per unit, or $1,000,000 (or $1,150,000 if the underwriters’ over-allotment option is exercised in full) in the aggregate, payable to the underwriters in cash upon the consummation of this initial public offering. Excludes certain fees and expenses payable to the underwriters in connection with this offering. See also “Underwriting” for a description of compensation and other items of value payable to the underwriters. |
| (2) | In addition, the Company will issue 175,000 ordinary shares (or up to 201,250 ordinary shares if the underwriters’ over-allotment option